MDLinx touts its MRA Verified panel

MDLinx, a division of M3 USA, had its physician panel verified by the Marketing Research Association (MRA), a process that involved a review of MDLinx's survey methodology, sample size and other procedural rules.

Craig Overpeck, chief technology officer at MDLinx, said the company's international panel of doctors—which includes 660,000 physicians across 24 specialties —was deemed “MRA Verified” after providing MRA with a self-assessment, and allowing the association to conduct an independent review. MDLinx provides medical news to doctors via emails, and, beginning three years ago, surveys doctors that receive the emails or sign up to participate in market research as panel member.

Physicians participate in a given survey for an MDLinx client by invitation, and use an invitation code to respond to survey questions.

Overpeck says the company's panel includes “one of every two oncologists in the US,” and approximately 130,000 US docs in total.
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.